These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 27149403)

  • 1. Finite Element Analysis of Denosumab Treatment Effects on Vertebral Strength in Ovariectomized Cynomolgus Monkeys.
    Lee DC; Varela A; Kostenuik PJ; Ominsky MS; Keaveny TM
    J Bone Miner Res; 2016 Aug; 31(8):1586-95. PubMed ID: 27149403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Denosumab treatment is associated with decreased cortical porosity and increased bone density and strength at the proximal humerus of ovariectomized cynomolgus monkeys.
    Haider IT; Sawatsky A; Zhu Y; Page R; Kostenuik PJ; Boyd SK; Edwards WB
    Bone; 2022 Nov; 164():116517. PubMed ID: 35961611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of denosumab, alendronate, or denosumab following alendronate on bone turnover, calcium homeostasis, bone mass and bone strength in ovariectomized cynomolgus monkeys.
    Kostenuik PJ; Smith SY; Samadfam R; Jolette J; Zhou L; Ominsky MS
    J Bone Miner Res; 2015 Apr; 30(4):657-69. PubMed ID: 25369992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Denosumab, a fully human RANKL antibody, reduced bone turnover markers and increased trabecular and cortical bone mass, density, and strength in ovariectomized cynomolgus monkeys.
    Ominsky MS; Stouch B; Schroeder J; Pyrah I; Stolina M; Smith SY; Kostenuik PJ
    Bone; 2011 Aug; 49(2):162-73. PubMed ID: 21497676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minodronic acid ameliorates vertebral bone strength by increasing bone mineral density in 9-month treatment of ovariectomized cynomolgus monkeys.
    Tanaka M; Mori H; Kawabata K; Mashiba T
    Bone; 2016 Jul; 88():157-164. PubMed ID: 27155564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased bone remodeling and porosity are associated with improved bone strength in ovariectomized cynomolgus monkeys treated with denosumab, a fully human RANKL antibody.
    Kostenuik PJ; Smith SY; Jolette J; Schroeder J; Pyrah I; Ominsky MS
    Bone; 2011 Aug; 49(2):151-61. PubMed ID: 21457806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A rat osteoporotic spine model for the evaluation of bioresorbable bone cements.
    Wang ML; Massie J; Perry A; Garfin SR; Kim CW
    Spine J; 2007; 7(4):466-74. PubMed ID: 17630145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-dimensional modeling of the effects of parathyroid hormone on bone distribution in lumbar vertebrae of ovariectomized cynomolgus macaques.
    Sato M; Westmore M; Clendenon J; Smith S; Hannum B; Zeng GQ; Brommage R; Turner CH
    Osteoporos Int; 2000; 11(10):871-80. PubMed ID: 11199192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained Modeling-Based Bone Formation During Adulthood in Cynomolgus Monkeys May Contribute to Continuous BMD Gains With Denosumab.
    Ominsky MS; Libanati C; Niu QT; Boyce RW; Kostenuik PJ; Wagman RB; Baron R; Dempster DW
    J Bone Miner Res; 2015 Jul; 30(7):1280-9. PubMed ID: 25684625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abaloparatide, a novel PTH receptor agonist, increased bone mass and strength in ovariectomized cynomolgus monkeys by increasing bone formation without increasing bone resorption.
    Doyle N; Varela A; Haile S; Guldberg R; Kostenuik PJ; Ominsky MS; Smith SY; Hattersley G
    Osteoporos Int; 2018 Mar; 29(3):685-697. PubMed ID: 29260289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between vertebral bone microstructure and estimated strength in elderly women: An ex-vivo HR-pQCT study of cadaveric spine.
    Yamada S; Chiba K; Okazaki N; Era M; Nishino Y; Yokota K; Yonekura A; Tomita M; Tsurumoto T; Osaki M
    Bone; 2019 Mar; 120():459-464. PubMed ID: 30553854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential treatment with basic fibroblast growth factor and PTH is more efficacious than treatment with PTH alone for increasing vertebral bone mass and strength in osteopenic ovariectomized rats.
    Iwaniec UT; Mosekilde L; Mitova-Caneva NG; Thomsen JS; Wronski TJ
    Endocrinology; 2002 Jul; 143(7):2515-26. PubMed ID: 12072383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cortical bone mineral density is increased by the cathepsin K inhibitor ONO-5334, which leads to a robust increase in bone strength: results from a 16-month study in ovariectomised cynomolgus monkeys.
    Yamada H; Ochi Y; Mori H; Nishikawa S; Hashimoto Y; Tanaka M; Deacon S; Kawabata K
    J Bone Miner Metab; 2019 Jul; 37(4):636-647. PubMed ID: 30357565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of long term treatment with high doses of odanacatib on bone mass, bone strength, and remodeling/modeling in newly ovariectomized monkeys.
    Duong LT; Pickarski M; Cusick T; Chen CM; Zhuo Y; Scott K; Samadfam R; Smith SY; Pennypacker BL
    Bone; 2016 Jul; 88():113-124. PubMed ID: 27126999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Denosumab and Teriparatide Transitions on Bone Microarchitecture and Estimated Strength: the DATA-Switch HR-pQCT study.
    Tsai JN; Nishiyama KK; Lin D; Yuan A; Lee H; Bouxsein ML; Leder BZ
    J Bone Miner Res; 2017 Oct; 32(10):2001-2009. PubMed ID: 28608571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Odanacatib, effects of 16-month treatment and discontinuation of therapy on bone mass, turnover and strength in the ovariectomized rabbit model of osteopenia.
    Duong LT; Crawford R; Scott K; Winkelmann CT; Wu G; Szczerba P; Gentile MA
    Bone; 2016 Dec; 93():86-96. PubMed ID: 27639811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of glucocorticoid on BMD, micro-architecture and biomechanics of cancellous and cortical bone mass in OVX rabbits.
    Liu X; Lei W; Wu Z; Cui Y; Han B; Fu S; Jiang C
    Med Eng Phys; 2012 Jan; 34(1):2-8. PubMed ID: 21775186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 16-month treatment with the cathepsin K inhibitor ONO-5334 on bone markers, mineral density, strength and histomorphometry in ovariectomized cynomolgus monkeys.
    Yamada H; Ochi Y; Mori H; Nishikawa S; Hashimoto Y; Nakanishi Y; Tanaka M; Bruce M; Deacon S; Kawabata K
    Bone; 2016 May; 86():43-52. PubMed ID: 26921823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of high-resolution peripheral quantitative computed tomography, finite element analysis and biomechanical testing in a pre-clinical model of osteoporosis: a study with odanacatib treatment in the ovariectomized adult rhesus monkey.
    Jayakar RY; Cabal A; Szumiloski J; Sardesai S; Phillips EA; Laib A; Scott BB; Pickarski M; Duong LT; Winkelmann CT; McCracken PJ; Hargreaves R; Hangartner TN; Williams DS
    Bone; 2012 Jun; 50(6):1379-88. PubMed ID: 22469953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abaloparatide improves cortical geometry and trabecular microarchitecture and increases vertebral and femoral neck strength in a rat model of male osteoporosis.
    Besschetnova T; Brooks DJ; Hu D; Nagano K; Nustad J; Ominsky M; Mitlak B; Hattersley G; Bouxsein ML; Baron R; Lanske B
    Bone; 2019 Jul; 124():148-157. PubMed ID: 31051317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.